Abstract
We have evaluated the use of biodegradable poly(DL-lactide-co-glycolide) microspheres for the controlled release of inter-leukin-2 (IL-2) and its modified forms: succinyl IL-2 (SIL-2) and polyethylene glycol-modified IL-2 (PEG IL-2). We show that a microsphere formulation can be prepared from PEG IL-2 using HSA as an excipient which, after an initial burst, releases 2-3% PEG IL-2 per day in a bioac-tive form continuously over a 20- to 30-day period.
Original language | English |
---|---|
Pages (from-to) | 755-758 |
Number of pages | 4 |
Journal | Bio/Technology |
Volume | 8 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1990 |